Cero Therapeutics Holdings, Inc.
CERO· OTC
CEROCero Therapeutics Holdings, Inc.
Filed Nov 19, 2024 · 10-Q · 50 days after period end · 0001213900-24-100245
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$4.23M | -$334.03K | $84.51K | $0.00 |
| EPS Diluted | -$170.22 | -$0.15 | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cero Therapeutics Holdings, Inc. · CIK 1870404 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 19, 2024 · 50 d after period end
